Company Coverage
Hartalega Holdings (HART MK): 1QFY27: Windfall Quarter, But Plenty Of Challenges Ahead
HOLD (Maintained)
Current price:
Target price:
Upside:
RM1.06
RM1.06
0.0%
Analyst
Highlights
- Harta’s 1QFY27 earnings improved significantly as lower volume sales (-7% qoq) were largely offset by much higher ASP (+27% qoq) due to the Iran war.
- Nevertheless, the upcoming 2Q-3QFY27 results may see margin compression as ASPs largely normalised, while raw material and energy costs
remained elevated.
- Structurally, intensifying China competition and oversupply dynamics continue to impact earnings. Maintain HOLD with an unchanged target price of RM1.06.
Analysis
- Within expectations. Hartalega Holdings (Harta) registered a 1QFY27 core net profit of RM72m (4QFY26: RM22m), after stripping out exceptional items. 1QFY27 earnings accounted for 49% and 46% of our and consensus full-year estimates respectively, but are deemed within expectations as we anticipate weaker earnings in the upcoming quarters for the rest of FY27.
- Stronger qoq revenue reflects meaningful ASP growth and modest MYR/USD rate uplift, offsetting weaker volume sales. Note that Harta’s
revenue increased 10% yoy and 18% qoq in 1QFY27, despite lower volume sales (-7% qoq). This was mainly due to a spike of ASPs in US dollar terms (+26% qoq) to US$25.71/’000 pieces, besides a marginal strengthening of the US dollar against the ringgit (+1.1% qoq).
- Operating metrics mixed, but margins improved on significant ASP hike. In 1QFY27, Harta charted a lower utilisation rate of 64% (4QFY26: 69%)
based on an adjusted capacity of around 36b. This mainly reflects softer demand as customers’ inventory replenishment was disrupted by the ongoing Iran war. Nevertheless, a meaningful ASP spike of 26% qoq towards US$25.71/’000 pieces significantly lifted revenue and profitability margin.Coupled with continuous cost rationalisation and efficiency enhancement efforts, EBITDA margins rose to 21.9% (+4ppt qoq).
- Sequentially weaker 2Q-3QFY27 anticipated. Following the de-escalation of the Iran war, ASPs moderated swiftly from the peak of US$26-27/’000 pcs in 1QFY27 to US$19-20/’000 pcs for Aug-Sep 26 shipments. Meanwhile, Harta is guiding potential margin compression in 2QFY27, as the group needs to lock in and deplete its raw material inventories which were purchased at higher costs due to the Iran war. Furthermore, the upcoming natural gas tariff’s upward revision in 3QFY27 will also lift energy costs and further pressure operating margins. Overall, we opine that softer ASPs and higher input costs will result in weaker earnings through the rest of FY27 for Harta.
- Stiff competition from China glovemakers remains as a structural threat. Given the severity of the current US tariffs on China-made medical gloves (147% in 2026), China glovemakers have largely reduced their exposure to the US market and re-channelled their sales to regions like Europe and Asia with more competitive price-cutting strategies. This has resulted in more challenging dynamics and declining profitability (lower ASPs and margins) for non-US sales. Over a mid- to long-term horizon, China glovemakers’ further expansion in Indonesia and Vietnam is likely to continue exerting competitive pressure, indirectly capping the ASP trend and profitability for Malaysian glovemakers. This also results in a structural de-rating on valuations.
- Automation efforts to achieve optimal efficiency and cost levels. Harta previously set aside RM285m for 2026-27 to further automate its production lines to optimise overall efficiency. Hence, margins could marginally recover in FY27 off FY25’s low base, coupled with an improvement in utilisation rate on better demand beginning 1QFY27 (Apr-Jun 26). The full commission of production lines in its Plant 9 which leverages automation and vision systems will also drive higher yields and lower labour costs. In FY27, management intends to restart and upgrade its Plant 3, lifting running capacity from current 27b pieces annually (after hibernating Plant 3 and 4) to 30b pieces by end-26.
- Healthy balance sheet with RM1.1b net cash. As of 1QFY27, Harta was in a net cash position of RM1.1b (~31% of market cap). Alongside an improving earnings outlook and restoration of dividend payout, Harta is well-positioned to navigate through the current challenges and further enhance its efficiency.
Highlights
- Harta’s 1QFY27 earnings improved significantly as lower volume sales (-7% qoq) were largely offset by much higher ASP (+27% qoq) due to the Iran war.
- Nevertheless, the upcoming 2Q-3QFY27 results may see margin compression as ASPs largely normalised, while raw material and energy costs
remained elevated.
- Structurally, intensifying China competition and oversupply dynamics continue to impact earnings. Maintain HOLD with an unchanged target price of RM1.06.
Analysis
- Within expectations. Hartalega Holdings (Harta) registered a 1QFY27 core net profit of RM72m (4QFY26: RM22m), after stripping out exceptional items. 1QFY27 earnings accounted for 49% and 46% of our and consensus full-year estimates respectively, but are deemed within expectations as we anticipate weaker earnings in the upcoming quarters for the rest of FY27.
- Stronger qoq revenue reflects meaningful ASP growth and modest MYR/USD rate uplift, offsetting weaker volume sales. Note that Harta’s
revenue increased 10% yoy and 18% qoq in 1QFY27, despite lower volume sales (-7% qoq). This was mainly due to a spike of ASPs in US dollar terms (+26% qoq) to US$25.71/’000 pieces, besides a marginal strengthening of the US dollar against the ringgit (+1.1% qoq).
- Operating metrics mixed, but margins improved on significant ASP hike. In 1QFY27, Harta charted a lower utilisation rate of 64% (4QFY26: 69%)
based on an adjusted capacity of around 36b. This mainly reflects softer demand as customers’ inventory replenishment was disrupted by the ongoing Iran war. Nevertheless, a meaningful ASP spike of 26% qoq towards US$25.71/’000 pieces significantly lifted revenue and profitability margin.Coupled with continuous cost rationalisation and efficiency enhancement efforts, EBITDA margins rose to 21.9% (+4ppt qoq).
- Sequentially weaker 2Q-3QFY27 anticipated. Following the de-escalation of the Iran war, ASPs moderated swiftly from the peak of US$26-27/’000 pcs in 1QFY27 to US$19-20/’000 pcs for Aug-Sep 26 shipments. Meanwhile, Harta is guiding potential margin compression in 2QFY27, as the group needs to lock in and deplete its raw material inventories which were purchased at higher costs due to the Iran war. Furthermore, the upcoming natural gas tariff’s upward revision in 3QFY27 will also lift energy costs and further pressure operating margins. Overall, we opine that softer ASPs and higher input costs will result in weaker earnings through the rest of FY27 for Harta.
- Stiff competition from China glovemakers remains as a structural threat. Given the severity of the current US tariffs on China-made medical gloves (147% in 2026), China glovemakers have largely reduced their exposure to the US market and re-channelled their sales to regions like Europe and Asia with more competitive price-cutting strategies. This has resulted in more challenging dynamics and declining profitability (lower ASPs and margins) for non-US sales. Over a mid- to long-term horizon, China glovemakers’ further expansion in Indonesia and Vietnam is likely to continue exerting competitive pressure, indirectly capping the ASP trend and profitability for Malaysian glovemakers. This also results in a structural de-rating on valuations.
- Automation efforts to achieve optimal efficiency and cost levels. Harta previously set aside RM285m for 2026-27 to further automate its production lines to optimise overall efficiency. Hence, margins could marginally recover in FY27 off FY25’s low base, coupled with an improvement in utilisation rate on better demand beginning 1QFY27 (Apr-Jun 26). The full commission of production lines in its Plant 9 which leverages automation and vision systems will also drive higher yields and lower labour costs. In FY27, management intends to restart and upgrade its Plant 3, lifting running capacity from current 27b pieces annually (after hibernating Plant 3 and 4) to 30b pieces by end-26.
- Healthy balance sheet with RM1.1b net cash. As of 1QFY27, Harta was in a net cash position of RM1.1b (~31% of market cap). Alongside an improving earnings outlook and restoration of dividend payout, Harta is well-positioned to navigate through the current challenges and further enhance its efficiency.
HOLD (Maintained)
Current price:
Target price:
Upside:
RM1.06
RM1.06
0.0%
Analyst
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at the following link: https://research-api.uobkayhian.com/assets/disclaimer/df64a6ea-7980-447c-ae9e-fd19b93257dc, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.
